Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3v2b | AR6 | Poly [ADP-ribose] polymerase 15 | 2.4.2.30 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3v2b | AR6 | Poly [ADP-ribose] polymerase 15 | 2.4.2.30 | 1.000 | |
| 5cb3 | APR | O-acetyl-ADP-ribose deacetylase | / | 0.510 | |
| 3q71 | AR6 | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.500 | |
| 4d86 | ADP | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.482 | |
| 3vfq | AR6 | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.480 | |
| 2bfq | AR6 | [Protein ADP-ribosylglutamate] hydrolase AF_1521 | 3.2.2 | 0.475 | |
| 5fsx | ADP | Uncharacterized protein | / | 0.472 | |
| 3iid | APR | Core histone macro-H2A.1 | / | 0.456 | |
| 1tys | DHF | Thymidylate synthase | / | 0.455 | |
| 1v4s | MRK | Glucokinase | 2.7.1.2 | 0.455 | |
| 3b6z | CO7 | Enoyl reductase LovC | 1 | 0.454 | |
| 1tys | TMP | Thymidylate synthase | / | 0.449 | |
| 2bpo | NAP | NADPH--cytochrome P450 reductase | / | 0.447 | |
| 3bgx | TMP | Thymidylate synthase | / | 0.444 | |
| 1pd9 | CO4 | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 4el5 | D1M | Glycogen phosphorylase, muscle form | 2.4.1.1 | 0.443 | |
| 5dp2 | NAP | CurF | / | 0.442 | |
| 3lsm | SFD | Pyranose 2-oxidase | / | 0.441 | |
| 3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.440 |